| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |